Latest News
Corcept Shares Leap 27% on Strong Lifyorli Launch and Upbeat Guidance
Corcept Therapeutics shares jumped 27.4% after Q2 revenue rose 32% to $256.1M, driven by Lifyorli sales of $47.6M. The company lifted its 2026 revenue outlook to $1.1-1.2 billion.
Chipotle Shares Surge 13% on Strong Q2 Sales, Margins Under Pressure
Chipotle shares surged 13% after Q2 comparable sales rose 2.2%, topping forecasts. Margins tightened as costs ate up nearly all incremental revenue, but a raised outlook and share repurchases supported the stock.
Cycurion Surges 400% on $54.6M Contract, But Cash Crunch Looms
Cycurion shares skyrocketed 400% following a $54.6 million state health-system contract, but liquidity issues and a negative working capital position pose immediate hurdles.
Nuwellis Rockets 130% on Pediatric Study Data and Revenue Update
Nuwellis shares skyrocketed 130% on heavy volume following a pediatric study update and preliminary Q2 revenue figures.
SK hynix ADR Surges 15% While Seoul Shares Plunge, Premium Hits 60%
SK hynix ADR surged 15% while Seoul shares fell 5.6%, creating a 60% premium. Q2 earnings missed consensus, with revenue and operating profit below estimates.
Caterpillar Rebounds After Baird Downgrade on Data Center Demand Worries
Caterpillar shares bounce back 3.1% after a 6.9% drop triggered by Baird's downgrade, which cut its price target to $900 from $1,200 over AI data-center demand fears.
Nebius Stock Surges 28% on Strong Q4 Revenue Outlook
Nebius (NASDAQ:NBIS) shares soared 28.4% to $190.34 after Q4 revenue forecasts of $1.52 billion drove investor enthusiasm.
